Role Played by MDSC in Colitis-associated Colorectal Cancer and Potential Therapeutic Strategies

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2024 May 8

PMID 38717677

Authors

Kang Wang

Yun Wang

Kai Yin

Affiliations

Soon will be listed here.

Abstract

Colitis-associated colorectal cancer has been a hot topic in public health issues worldwide. Numerous studies have demonstrated the significance of myeloid-derived suppressor cells (MDSCs) in the progression of this ailment, but the specific mechanism of their role in the transformation of inflammation to cancer is unclear, and potential therapies targeting MDSC are also unclear. This paper outlines the possible involvement of MDSC to the development of colitis-associated colorectal cancer. It also explores the immune and other relevant roles played by MDSC, and collates relevant targeted therapies against MDSC. In addition, current targeted therapies for colorectal cancer are analyzed and summarized.

Citing Articles

Identification of PANoptosis associated lncRNAs associated with clinical prognosis and immune infiltration microenvironment in colon adenocarcinoma.

Wang Y, Zhao S, Du S, Xia T, Song L, Xia M Discov Oncol. 2025; 16(1):83.

PMID: 39853491 PMC: 11759722. DOI: 10.1007/s12672-025-01838-3.

References

Youn J, Nagaraj S, Collazo M, Gabrilovich D . Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol. 2008; 181(8):5791-802. PMC: 2575748. DOI: 10.4049/jimmunol.181.8.5791. View

Wang Y, Liu H, Zhang Z, Bian D, Shao K, Wang S . G-MDSC-derived exosomes mediate the differentiation of M-MDSC into M2 macrophages promoting colitis-to-cancer transition. J Immunother Cancer. 2023; 11(6). PMC: 10410840. DOI: 10.1136/jitc-2022-006166. View

Yvellez O, Rai V, Sossenheimer P, Hart J, Turner J, Weber C . Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study. Inflamm Bowel Dis. 2020; 27(2):203-206. PMC: 7813748. DOI: 10.1093/ibd/izaa047. View

Chen X, Qiu T, Zhu Y, Sun J, Li P, Wang B . A Single-Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer. Oncologist. 2019; 24(7):883-e407. PMC: 6656475. DOI: 10.1634/theoncologist.2019-0164. View

Galluzzi L, Humeau J, Buque A, Zitvogel L, Kroemer G . Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol. 2020; 17(12):725-741. DOI: 10.1038/s41571-020-0413-z. View

Fakih M, Sandhu J, Lim D, Li X, Li S, Wang C . Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy: A Phase 1 Nonrandomized Clinical Trial. JAMA Oncol. 2023; 9(5):627-634. PMC: 9999273. DOI: 10.1001/jamaoncol.2022.7845. View

Heinrich M, Jones R, George S, Gelderblom H, Schoffski P, von Mehren M . Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nat Med. 2024; 30(2):498-506. PMC: 10878977. DOI: 10.1038/s41591-023-02734-5. View

Wang C, Zheng X, Zhang J, Jiang X, Wang J, Li Y . CD300ld on neutrophils is required for tumour-driven immune suppression. Nature. 2023; 621(7980):830-839. DOI: 10.1038/s41586-023-06511-9. View

Kang Y, Ryu M, Park S, Kim J, Kim J, Cho S . Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy. Ann Oncol. 2018; 29(5):1220-1226. DOI: 10.1093/annonc/mdy055. View

10.

Kim R, Hashimoto A, Markosyan N, Tyurin V, Tyurina Y, Kar G . Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022; 612(7939):338-346. PMC: 9875862. DOI: 10.1038/s41586-022-05443-0. View

11.

Wang Y, Ding Y, Deng Y, Zheng Y, Wang S . Role of myeloid-derived suppressor cells in the promotion and immunotherapy of colitis-associated cancer. J Immunother Cancer. 2020; 8(2). PMC: 7555106. DOI: 10.1136/jitc-2020-000609. View

12.

Johnson M, Dudek A, Sukari A, Call J, Kunk P, Lewis K . ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study. Clin Cancer Res. 2022; 28(12):2517-2526. PMC: 9359741. DOI: 10.1158/1078-0432.CCR-21-3009. View

13.

Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M . Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023; 72(2):338-344. DOI: 10.1136/gutjnl-2022-327736. View

14.

Ibrahim M, Klement J, Lu C, Redd P, Xiao W, Yang D . Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis. Cell Rep. 2018; 25(11):3036-3046.e6. PMC: 6319669. DOI: 10.1016/j.celrep.2018.11.050. View

15.

Reilley M, McCoon P, Cook C, Lyne P, Kurzrock R, Kim Y . STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial. J Immunother Cancer. 2018; 6(1):119. PMC: 6240242. DOI: 10.1186/s40425-018-0436-5. View

16.

Karpisheh V, Nikkhoo A, Hojjat-Farsangi M, Namdar A, Azizi G, Ghalamfarsa G . Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer. Prostaglandins Other Lipid Mediat. 2019; 144:106338. DOI: 10.1016/j.prostaglandins.2019.106338. View

17.

Chen H, Pan Y, Zhou Q, Liang C, Wong C, Zhou Y . METTL3 Inhibits Antitumor Immunity by Targeting mA-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer. Gastroenterology. 2022; 163(4):891-907. DOI: 10.1053/j.gastro.2022.06.024. View

18.

Zhang K, Zakeri A, Alban T, Dong J, Ta H, Zalavadia A . VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms. Cell Rep. 2024; 43(1):113661. PMC: 10851928. DOI: 10.1016/j.celrep.2023.113661. View

19.

Tsukamoto H, Nishikata R, Senju S, Nishimura Y . Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression. Cancer Immunol Res. 2014; 1(1):64-76. DOI: 10.1158/2326-6066.CIR-13-0030. View

20.

Yang X, Li G, Lou P, Zhang M, Yao K, Xiao J . Excessive nucleic acid R-loops induce mitochondria-dependent epithelial cell necroptosis and drive spontaneous intestinal inflammation. Proc Natl Acad Sci U S A. 2023; 121(1):e2307395120. PMC: 10769860. DOI: 10.1073/pnas.2307395120. View